Companies with AI applications in place are redesigning their commercial model and outperforming the competition. Agentic AI is the next step in that evolution.
Education
- MBA, Kellogg School of Management
- BA, Economics, University of Tokyo
Sam Karita is a core member of Boston Consulting Group’s Health Care, and Corporate Finance & Strategy practices. He is also a leader in the firm’s work in medical devices and medtech for Northeast Asia. In 2022, he launched BHI Japan, the Japan hub of the BCG Henderson Institute (now the BCG Institute), the firm's think tank, and led it until October 2026.
Since joining BCG, Sam has worked closely with clients in a wide range of industries including pharmaceuticals, medical devices, consumer goods, media and entertainment, high-tech, and telecommunications. He has in-depth experience supporting clients on strategy development and implementation, digital transformation, innovation, productivity improvement across the value chain, and M&A.
Before joining BCG, Sam worked for the Industrial Bank of Japan, currently Mizuho Financial Group, where he was in charge of corporate finance for several major accounts.
